Area of research
Hematology · Internal Medicine
Research interest
Research interests include Venous Thromboembolism Diagnosis and Management, Platelet Disorders and Treatments, Heparin-Induced Thrombocytopenia and Thrombosis, and Atrial Fibrillation Management and Outcomes.
Delphi consensus recommendations for neuraxial anesthesia in adults with platelet disorders and coagulation defects: communication from the ISTH SSC Subcommittee on von Willebrand Factor
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease
Practical guide to the diagnosis and management of heparin-induced thrombocytopenia
American Society of Hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: executive summary
Heparin-induced thrombocytopenia: An illustrated review
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients
Postoperative bleeding complications in patients with hemophilia undergoing major orthopedic surgery: A prospective multicenter observational study
Thrombocytopenia and liver disease: pathophysiology and periprocedural management
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
Redefining outcomes in immune TTP: an international working group consensus report
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines
American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences
American Society of Hematology 2019 guidelines for immune thrombocytopenia
The risk of major bleeding in patients with suspected heparin‐induced thrombocytopenia
Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
A cross-sectional analysis of cardiovascular disease in the hemophilia population
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
Spk-9001: Adeno-Associated Virus Mediated Gene Transfer for Hemophilia B Achieves Sustained Mean Factor IX Activity Levels of >30% without Immunosuppression
Practical Management of Anticoagulation in Patients With Atrial Fibrillation
Microsurgery and the Hypercoagulable State